Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Servier finalizes acquisition of Day One Biopharmaceuticals to bolster oncology portfolio

23/04/2026 Published by ViNe

Servier, a global independent pharmaceutical group, has concluded its tender offer for Day One Biopharmaceuticals, acquiring all outstanding common stock... Read more

Tags: #M&A

Ray Therapeutics secures $125m to advance optogenetic vision therapies

23/04/2026 Published by ViNe

Ray Therapeutics has successfully raised $125 million in an oversubscribed Series B funding round. Led by Janus Henderson Investors and... Read more

Category: Uncategorized

Tags: #Global Trends

Expanded access to type 1 diabetes delay therapy for toddlers

23/04/2026 Published by ViNe

The US Food and Drug Administration (FDA) has officially authorized the use of Tzield (teplizumab-mzwv) to postpone the onset of... Read more

Category: Uncategorized

Tags: #Global Trends

Policy Gridlock: US Government to Shoulder GLP-1 Costs as Insurers Opt Out of Pilot

23/04/2026 Published by ViNe

The Centers for Medicare & Medicaid Services (CMS) hit a significant roadblock in its obesity treatment strategy. Due to a... Read more

Category: Uncategorized

Tags: #Global Trends

AbbVie’s Strategic Milestone: $1.4B Investment in AI-Integrated Manufacturing in North Carolina

23/04/2026 Published by ViNe

AbbVie announced a landmark $1.4 billion investment to establish a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. This project... Read more

Category: Uncategorized

Tags: #Global Trends

Merck Partners with Google in $1B Enterprise Deal to Drive “Agentic AI” Transformation

23/04/2026 Published by ViNe

On April 22, 2026, Merck & Co. revealed a landmark partnership with Google Cloud valued at up to $1 billion.... Read more

Category: Uncategorized

Tags: #Global Trends

Amneal Seizes “Golden Era” with $1.1B Acquisition of Kashiv BioSciences

23/04/2026 Published by ViNe

On April 22, 2026, Amneal Pharmaceuticals announced its strategic acquisition of Kashiv BioSciences for $1.1 billion. This move positions Amneal... Read more

Category: Uncategorized

Tags: #M&A